Autologous Endometrial Coculture (AECCT) (AECCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01472861
Recruitment Status : Terminated (poor recruitment)
First Posted : November 17, 2011
Last Update Posted : June 12, 2015
Information provided by (Responsible Party):
Weill Medical College of Cornell University

Brief Summary:
The purpose of this study is to determine if the use of Autologous Endometrial Coculture (AECC) in young in vitro fertilization (IVF) patients with poor ovarian reserve improves pregnancy outcome.

Condition or disease Intervention/treatment Phase
Infertility Procedure: AECC (Autologous endometrial coculture) Other: no endometrial biopsy or Autologous endometrial coculture (AECC) performed Not Applicable

Detailed Description:
Young women with poor ovarian reserve are commonly given a poor prognosis for IVF success. Standard culture media for fertilizing oocytes (unfertilized eggs) is commonly used in IVF which closely resembles tubal fluid. Efforts to create optimal culture conditions for fertilization of human embryos for women with poor quality embryos and/or repeated implantation failures have been developed at our center by using AECC. AECC involves placing a patient's fertilized eggs on top of a layer of cells from her own uterine lining, creating a more natural environment for embryo development and maximizing the chance for IVF pregnancy. The investigators will prospectively randomize young patients (≤ age 38 years) poor ovarian reserve to AECC or no AECC with standard culture media to study pregnancy outcome.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial Evaluating Autologous Endometrial Coculture (AECC) As An Effective Tool For Young Patients With Poor Ovarian Reserve
Study Start Date : October 2009
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Biopsy
U.S. FDA Resources

Arm Intervention/treatment
Placebo Comparator: No AECC
Routine procedures without AECC
Other: no endometrial biopsy or Autologous endometrial coculture (AECC) performed
routine procedures with out biopsy
Experimental: AECC
Endometrial biopsy and Autologous endometrial coculture
Procedure: AECC (Autologous endometrial coculture)
endometrial biopsy with autologous endometrial coculture

Primary Outcome Measures :
  1. Pregnancy outcome [ Time Frame: 1 month ]

Secondary Outcome Measures :
  1. Embryo quality [ Time Frame: 1 month ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 38 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy women undergoing IVF at CRMI
  • Age ≤ 38 years
  • Poor ovarian reserve with antral follicle count less than 6 follicles, cycle day 2/3 FSH > 12 ng/ml, AMH < 0.5 ng/ml

Exclusion Criteria:

  • Healthy women undergoing IVF with male factor, severe endometriosis, or tubal factor infertility
  • Donor patients
  • Contraindications for the use of gonadotropins (i.e. pregnancy, lactation, undiagnosed vaginal bleeding or ovarian cysts)
  • Recent or current medical conditions where the patient is not medically stable to undergo stimulation or egg retrieval, HIV infection, diabetes, cardiovascular disease, gastrointestinal, hepatic disease, renal or pulmonary disease.
  • Any patient who is not a candidate for IVF

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01472861

United States, New York
Center for Reproducutve Medicine; Weill Cornell Medical College
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Principal Investigator: Spandorfer Steven, MD Weill Medical College

Additional Information:
Responsible Party: Weill Medical College of Cornell University Identifier: NCT01472861     History of Changes
Other Study ID Numbers: 0903010293
First Posted: November 17, 2011    Key Record Dates
Last Update Posted: June 12, 2015
Last Verified: June 2015

Keywords provided by Weill Medical College of Cornell University:
endometrial biopsy
IVF poor responders

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female